An update on acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)

Chair: John Gribben

AML and MDS: what's new from ASH 2018? - Valeria Santini

After participating in this broadcast you should be able to:
- Predict whether recent clinical data relating to AML and MDS will impact daily clinical practice.